Dyslipidemia and pediatric obesity

Pediatric Clinics of North America

Volumn 58, Issue 6, 2011, Pages 1363-1373

  Cook, Stephen ^a   Kavey, Rae Ellen W ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Adolescents; Children; Dyslipidemia; Epidemiology; Insulin resistance; Metabolic syndrome; Obesity; Waist circumference

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 3 FATTY ACID ESTER; STATIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; CARDIOVASCULAR RISK; CHILD CARE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG SAFETY; DYSLIPIDEMIA; EXERCISE; GLYCEMIC INDEX; HUMAN; LIFESTYLE MODIFICATION; LOW CARBOHYDRATE DIET; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; TASTE DISORDER; TREND STUDY; WAIST CIRCUMFERENCE;

ADOLESCENT; ALGORITHMS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIET; DYSLIPIDEMIAS; EXERCISE; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; LIFE STYLE; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; UNITED STATES;

EID: 81255210923     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.09.003     Document Type: Review

References (54)

1. Ford E.S., Ajani U.A., Croft J.B., et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007, 356:2388-2398.
2. Ford E.S., Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol 2007, 50:2128-2132.
3. Heidenreich P.A., Trogdon J.G., Khavjou O.A., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011, 123(8):933-944.
4. Bibbins-Domingo K., Coxson P., Pletcher M.J., et al. Adolescent overweight and future adult coronary heart disease. N Engl J Med 2007, 357:2371-2379.
5. McGill H.C., McMahan C.A., Zieske A.W., et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000, 20(8):1998-2004.
6. Berenson G.S., Srinivasan S.R., Bao W., et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998, 338(23):1650-1656.
7. NCEP Expert Panel of Blood Cholesterol Levels in Children and Adolescents. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992, 89:495-501.
8. Kwiterovich P.O. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab 2008, 93(11):4200-4209.
9. Ford E.S., Li C., Zhao G., et al. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation 2009, 119:1108-1115.
10. Daniels S.R., Greer F.R., AAP Committee on Nutrition Lipid screening and cardiovascular health in childhood. Pediatrics 2008, 122:198-208.
11. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA 2010, 303:242-249.
12. Skelton J., Cook S., Auinger P., et al. Prevalence and trends of severe obesity among US children and adolescents. Acad Pediatr 2009, 9(5):322-329.
13. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
14. Cook S., Weitzman M., Auinger P., et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003, 157:821-827.
15. Li C., Ford E., Mokdad A., et al. Recent waist circumference trends and waist-to-height ratio among US children and adolescents. Pediatrics 2006, 118(5):e1390-e1398.
16. Cook S., Auinger P., Li C., et al. Metabolic Syndrome Rates in U.S. Adolescents, from the National Health and Nutrition and Examination Survey 1999-2002. J Pediatr 2008, 152(2):165-170.
17. Freedman D.S., Mei Z., Srinivasan S.R., et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr 2007, 150(1):12-17.
18. McGill H.C., McMahan C.A., Herderick E.E., et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002, 105:2712-2718.
19. Centers for Disease Control and Prevention Prevalence of abnormal lipid levels among youths-United States, 1999-2006. MMWR Morb Mortal Wkly Rep 2010, 59:29-33.
20. Laakso M., Sarlund H., Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990, 10:223-231.
21. Blake G.J., Otvos J.D., Rifai N., et al. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 2002, 106:1930-1937.
22. Kuller L., Arnold A., Tracy R., et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study. Arterioscler Thromb Vasc Biol 2002, 22:1175-1180.
23. Tabas I., Williams K.J., Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832-1844.
24. Campos H., Arnold K.S., Balestra M.E., et al. Differences in receptor binding of LDL subfractions. Arterioscler Thromb Vasc Biol 1996, 16:794-801.
25. Barter P., Gotto A.M., LaRosa J.C., et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007, 357:1301-1310.
26. Paramsothy P., Knopp R.H., Bertoni A.G., et al. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010, 56(13):1034-1041.
27. Koivistoinen T., Hutri-Kahonen N., Juonala M., et al. Apolipoprotein B is related to arterial pulse wave velocity in young adults: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 2011, 214:220-224.
28. Kathiresan S., Otvos J.D., Sullivan L.M., et al. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006, 113:20-29.
29. Cromwell W.C., Otvos J.D., Keyes M.J., et al. LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study-Implications for LDL Management. J Clin Lipidol 2007, 1:583-592.
30. Juonala M., Viikari J.S., Ronnemaa T., et al. Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2008, 28(5):1012-1017.
31. Ford E.S., Mokdad A.H., Ajani U.A. Trends in risk factors for cardiovascular disease among children and adolescents in the United States. Pediatrics 2004, 114:1534-1544.
32. Epstein L.H., Kuller L.H., Wing R.R., et al. The effect of weight control on lipid changes in obese children. Am J Dis Child 1989, 143(4):454-457.
33. Nemet D., Barkan S., Epstein Y., et al. Short- and long-term beneficial effects of a combined dietary-behavioral-physical activity intervention for the treatment of childhood obesity. Pediatrics 2005, 115(4):e443-e449.
34. Kang H.S., Gutin B., Barbeau P., et al. Physical training improves insulin resistance syndrome markers in obese adolescents. Med Sci Sports Exerc 2002, 34(12):1920-1927.
35. Becque M.D., Katch V.L., Rocchini A.P., et al. Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics 1988, 81(5):605-612.
36. Siri-Tarino P.W., Williams P.T., Fernstrom H.S., et al. Reversal of small, dense LDL subclass phenotype by normalization of adiposity. Obesity (Silver Spring) 2009, 17:1768-1775.
37. Ferguson M.A., Gutin B., Le N.A., et al. Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int J Obes Relat Metab Disord 1999, 23(8):889-895.
38. Watts K., Beye P., Siafarikas A., et al. Effects of exercise training on vascular function in obese children. J Pediatr 2004, 144(5):620-625.
39. Woo K.S., Chook P., Yu C.W., et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004, 109(16):1981-1986.
40. Pieke B., von Eckardstein A., Gulbahce E., et al. Treatment of hypertriglyceridemia by two diets rich in unsaturated fatty acids or in carbohydrates: effects on lipoprotein subclasses, lipolytic enzymes, lipid transfer proteins, insulin and leptin. Int J Obes Relat Metab Disord 2000, 24:1286-1296.
41. Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids 2010, 45:907-914.
42. Sondike S.B., Copperman N., Jacobson M.S. Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factors in overweight adolescents. J Pediatr 2003, 142(3):253-258.
43. Ohta T., Nakamura R., Ikeda Y., et al. Follow up study on children with dyslipidaemia detected by mass screening at 18 months of age: effect of 12 months dietary treatment. Eur J Pediatr 1993, 152(11):939-943.
44. Pereira M.A., Swain J., Goldfine A.B., et al. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA 2004, 292(20):2482-2490.
45. Ebbeling C.B., Leidig M.M., Sinclair K.B., et al. Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults. Am J Clin Nutr 2005, 81(5):976-982.
46. Ebbeling C.B., Leidig M.M., Feldman H.A., et al. Effects of a low glycemic-load vs low fat diet in obese young adults. JAMA 2007, 297:2092-2102.
47. Ebbeling C.B., Leidig M.M., Sinclair K.B., et al. A reduced glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med 2003, 157:773-779.
48. NHLBI expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics 2011;(Suppl 128)6.
49. Goldberg R.B., Sabharal A.K. Fish oil in the treatment of dyslipidemia. Curr Opin Endocrinol Diabetes Obes 2008, 15:167-174.
50. Engler M.M., Engler M.B., Malloy M.J., et al. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 2005, 95(7):869-871.
51. Guerib M., Egger P., Soudant C., et al. Dose dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Atherosclerosis 2002, 163:287-296.
52. van der Graaf A., Rodenburg J., Vissers M.N., et al. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia. J Pediatr 2008, 152(6):873-878.
53. Wheeler K.A., West R.J., Lloyd J.K., et al. Double blind trial of bezafibrate in familial hypercholesterolaemia. Arch Dis Child 1985, 60(1):34-37.
54. Colletti R.B., Neufeld E.J., Roff N.K., et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993, 92:78-82.